Vascular News and Research

RSS

ISCT launches commercial development focus group addressing Cell Therapies for Peripheral Vascular Disease

In keeping with its commitment to connect industry, regulatory experts, therapeutic societies and translational centers to advance emerging cellular therapies, ISCT announces its first commercial development focus group addressing Cell Therapies for Peripheral Vascular Disease (PVD).

20 Jan 2011

Pervasis pursues matrix-embedded endothelial cell-based therapy to target and regulate cell stroma

Pervasis Therapeutics, Inc. today announced that the company is pursuing a matrix-embedded endothelial cell-based therapy (PVS-30200) to target and regulate cell stroma (the tumor environment or "ecosystem" that is comprised of various supporting cell types distinct from cancer cells) in order to prevent key processes that play a role in advancing solid tumor growth and metastasis.

20 Jan 2011

NYU Langone to expand Emergency Department and dedicate separate area for pediatric emergency care

NYU Langone Medical Center today announced its plan to transform its Emergency Department (ED) into a state-of the-art emergency facility to meet the growing need for emergency care services in the community. Once completed, the new facility will nearly triple the size of the current ED and will include for the first time a separate area dedicated to pediatric emergency services.

20 Jan 2011

Endothelial cells may play a role in controlling cancer behavior: New study

MIT scientists have discovered that cells lining the blood vessels secrete molecules that suppress tumor growth and keep cancer cells from invading other tissues, a finding that could lead to a new way to treat cancer.

20 Jan 2011

Boston Scientific announces merger agreement to acquire Atritech

Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which the Company will acquire Atritech, a privately held company based in Plymouth, Minnesota.

19 Jan 2011

New GORE VIABAHN Endoprosthesis is now available in Europe

W. L. Gore & Associates today announced the European availability of the GORE VIABAHN Endoprosthesis on a lower profile delivery system. The announcement came during the Leipzig Interventional Course in Germany, where European interventionalists gathered to discuss new approaches in treating patients suffering from peripheral artery disease.

19 Jan 2011

Hotspur announces successful completion of GPSCath Catheter in peripheral angioplasty surgery

Hotspur Technologies, announced today that Dr. Greg Sampognaro, Interventional Cardiologist at P & S Surgical Hospital in Monroe, Louisiana, successfully completed the first use of the GPSCath Balloon Dilatation Catheter in an intervention to treat a blocked peripheral artery.

18 Jan 2011

Palomar Medical introduces Artisan Aesthetic System to provide laser skin resurfacing treatment

Palomar Medical Technologies, a leading researcher and developer of lasers and pulsed-light systems for aesthetic treatments, is pleased to announce that the Artisan Aesthetic System is now being shipped.

18 Jan 2011

EverFlex+ Self-Expanding Peripheral Stent System is now available in Europe

Covidien, a leading global provider of healthcare products, today announced availability of the EverFlex+™ Self-Expanding Peripheral Stent System in Europe.

18 Jan 2011

12-HETE enzyme inhibition can prevent ischemic retinopathy: Study

The inhibition or removal of an enzyme may prevent or treat ischemic retinopathy by stalling growth of unwanted vessels in the retina, Medical College of Georgia researchers say.

14 Jan 2011

FibroGen initiates FG-3019 open-label phase 2 study in idiopathic pulmonary fibrosis

FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.

13 Jan 2011

Pfizer initiates rolling submission of crizotinib NDA for ALK-positive advanced NSCLC

Pfizer Inc. announced today that it has initiated the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for crizotinib (PF-02341066), an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. Pfizer expects to complete the submission in the first half of 2011.

13 Jan 2011

Study highlights important clinical implications of miR-503 in diabetes-associated vascular complications

New research has found one of the smallest entities in the human genome, micro-RNA, could increase the risk of limb amputation in diabetic patients who have poor blood flow.

13 Jan 2011

Winter weather tips for people with high blood pressure

It's sad but true. Celebrity groundhog Punxsutawney Phil of PA and his relatives accurately predict the end or extension of winter only 39 percent of the time according to the United States National Climate Center.

12 Jan 2011

Surge in cataract surgeries fuels intraocular lens market to almost $1.4 billion

According to two new reports by iData Research, the leading global authority in medical device and pharmaceutical market research, growth in the use of optical coherence tomography (OCT) for the detection of ocular conditions will drive the U.S. diagnostic ophthalmic market to over $650 million by 2017.

12 Jan 2011

Rice, BCM discovery addresses key roadblock to growing replacement tissues, organs

Researchers from Rice University and Baylor College of Medicine (BCM) have broken one of the major roadblocks on the path to growing transplantable tissue in the lab: They've found a way to grow the blood vessels and capillaries needed to keep tissues alive.

12 Jan 2011

Apixaban drug raises hope for DVT prevention in patients undergoing hip replacement surgery

A worldwide research consortium that includes the University of Oklahoma Health Sciences Center has proven that a new drug is more effective and easier to use than current medicines in the prevention of blood clots following hip replacement surgery.

12 Jan 2011

Vermillion receives USPTO patent for PAD biomarker

Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued patent number 7,867,719 entitled "Beta-2 microglobulin as a biomarker for peripheral artery disease" to the Company.

12 Jan 2011

BPH, hair loss prevention drugs may produce adverse side effects in men

Researchers from Boston University School of Medicine, in collaboration with colleagues at Lahey Clinic and from Denmark and Germany, have found that 5a-reductase inhibitors, while improving urinary symptoms in patients with benign prostatic hyperplasia and possible hair loss prevention, produces significant adverse effects in some individuals including loss of libido, erectile dysfunction, ejaculatory dysfunction and potential depression.

12 Jan 2011

AccessClosure launches Mynx Cadence Vascular Closure Device

AccessClosure, the U.S. market leader in extravascular closure devices, announced today the launch of its next generation product, the Mynx Cadence Vascular Closure Device.

11 Jan 2011

Vascular News and Research

ISCT launches commercial development focus group addressing Cell Therapies for Peripheral Vascular Disease

Pervasis pursues matrix-embedded endothelial cell-based therapy to target and regulate cell stroma

NYU Langone to expand Emergency Department and dedicate separate area for pediatric emergency care

Endothelial cells may play a role in controlling cancer behavior: New study

Boston Scientific announces merger agreement to acquire Atritech

New GORE VIABAHN Endoprosthesis is now available in Europe

Hotspur announces successful completion of GPSCath Catheter in peripheral angioplasty surgery

Palomar Medical introduces Artisan Aesthetic System to provide laser skin resurfacing treatment

EverFlex+ Self-Expanding Peripheral Stent System is now available in Europe

12-HETE enzyme inhibition can prevent ischemic retinopathy: Study

FibroGen initiates FG-3019 open-label phase 2 study in idiopathic pulmonary fibrosis

Pfizer initiates rolling submission of crizotinib NDA for ALK-positive advanced NSCLC

Study highlights important clinical implications of miR-503 in diabetes-associated vascular complications

Winter weather tips for people with high blood pressure

Surge in cataract surgeries fuels intraocular lens market to almost $1.4 billion

Rice, BCM discovery addresses key roadblock to growing replacement tissues, organs

Apixaban drug raises hope for DVT prevention in patients undergoing hip replacement surgery

Vermillion receives USPTO patent for PAD biomarker

BPH, hair loss prevention drugs may produce adverse side effects in men

AccessClosure launches Mynx Cadence Vascular Closure Device

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News